LTR Pharma

CompanyAustralia

LTR Pharma develops one asset. Mostly small molecule acting on PDE5A; based in Australia.

1
Asset
Furthest stage
Not known
0
Trials
1
Signal

Pipeline

1
  • Vardenafil

    Inhibits phosphodiesterase 5, enhancing nitric oxide-mediated blood flow to support erections.

    Stage not known, Small molecule, PDE5A

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Signals1
  • Similar companies1

Intelligence